TrialAdvances in therapy2025

Onset and Long-Term Maintenance of Optimal Itch Response in Adult Patients with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab: Post Hoc Analysis from Two Phase 3 Trials.

Sonja Ständer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.